Innoventric
PrivateLast Round
Series B
Oct 29, 2024
Total Funding Raised
$42.5M
Company Overview
Innoventric is a medical device company that develops transcatheter solutions for the treatment of tricuspid regurgitation and right heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innoventric Comparables
Compare Innoventric with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| P&F Products & Features GmbH | 91% | |
| CroíValve | 89% | |
| VDyne | 87% |
For institutional investors. Book with your work email.
Innoventric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2024 | ||||
| Series A | Nov 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Innoventric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B, Series A |
| RA Capital Management | Series B |
| BRM Group | Seed, Series A, Series B |
| Mivtach Shamir Holdings | Series B, Seed, Series A |
| JG Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 677% MoM, from 189 to 1.5K.
- Oct 29, 2024
$29M round led by RA Capital Management.
For institutional investors. Book with your work email.
Innoventric Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Innoventric's valuation, stock price, and market status.
Is Innoventric a public or private company?
Innoventric is a private company.
What is the current stock price of Innoventric?
Innoventric is a private company, so its shares have no public market price. Caplight tracks Innoventric's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innoventric worth (valuation)?
Valuation information for Innoventric is not publicly available.
Can I buy Innoventric stock?
Innoventric shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innoventric's last funding round?
Innoventric's most recent funding round was Series B on October 29, 2024.
Who are the main investors in Innoventric?
Key investors in Innoventric include European Innovation Council Fund, RA Capital Management.
Will Innoventric IPO soon?
No public IPO plans have been announced for Innoventric.
How can I track Innoventric secondary market activity?
Caplight tracks bids, offers, and trades in Innoventric's shares on secondary markets.